Surgery Doctors in Pacific Grove, CA Accepting Medicare

1 Surgery doctors found. Showing 1 - 1

Dr. Kevin Yang, MD Surgery Medicare: Medicare Enrolled Practice Location: 827 Congress Ave, Pacific Grove, CA 93950 Phone: 443-257-6826

News Archive

Immunocore's Phase IIa clinical trial for IMCgp100 in melanoma initiates in the UK and USA

Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.

AtriCure's Bipolar RF Ablation System shows promising results in persistent Afib patients

A leading German cardiovascular heart center reported promising mid-term results for the surgical treatment of persistent atrial fibrillation during last week's International Society for Minimally Invasive Cardiothoracic Surgery meeting being held in Prague, Czech Republic.

UNICEF chief to step down after term ends in 2010

UNICEF Executive Director Ann Veneman will not seek a second term as head of the agency after her term expires in a few months, U.N. Secretary-General Ban Ki-moon announced "with great regret" on Wednesday, Xinhua reports. In a statement, Ban said that Veneman "fulfilled her mandate with immense dedication, and I have been impressed by her extraordinary energy and determination to improve children's health, education and well-being around the world" (12/23).

Study finds combustible tobacco cigarettes cost less than e-cigarettes

Combustible tobacco cigarettes cost less to purchase than equivalent amounts of electronic cigarettes (e-cigarettes) in 44 of 45 countries sampled around the world, according to a new American Cancer Society study. The study, appearing in Tobacco Control, concludes the gap exists despite the fact that e-cigarettes are not yet widely subjected to comparable excise taxes as combustible cigarettes.

Cipher Pharmaceuticals enrolls first patient in Phase III study of CIP-ISOTRETINOIN

Cipher Pharmaceuticals Inc. today announced that it has enrolled the first patient in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne.

Read more Medical News

› Verified 5 days ago